Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | Rho-associated, coiled-coil containing protein kinase 2 | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium falciparum | eukaryotic initiation factor 4A | 0.0205 | 0.3624 | 0.5 |
Mycobacterium ulcerans | putative regulatory protein | 0.0041 | 0.0549 | 1 |
Brugia malayi | hypoxia-induced factor 1 | 0.0171 | 0.2979 | 0.2979 |
Echinococcus multilocularis | Aryl hydrocarbon receptor nuclear | 0.0014 | 0.0054 | 0.0148 |
Loa Loa (eye worm) | hypoxia-induced factor 1 | 0.0171 | 0.2979 | 0.2979 |
Echinococcus multilocularis | aryl hydrocarbon receptor | 0.0014 | 0.0054 | 0.0148 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0176 | 0.3074 | 0.8482 |
Onchocerca volvulus | 0.0175 | 0.3067 | 0.6511 | |
Trypanosoma cruzi | Eukaryotic initiation factor 4A-1 | 0.0205 | 0.3624 | 1 |
Loa Loa (eye worm) | pax transcription factor protein 2 | 0.0263 | 0.471 | 0.471 |
Onchocerca volvulus | 0.0041 | 0.0549 | 0.1166 | |
Brugia malayi | Pax transcription factor protein 2 | 0.0263 | 0.471 | 0.471 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0205 | 0.3624 | 1 |
Echinococcus granulosus | Aryl hydrocarbon receptor nuclear | 0.0014 | 0.0054 | 0.0148 |
Trypanosoma cruzi | PAS-domain containing phosphoglycerate kinase, putative | 0.0014 | 0.0054 | 0.002 |
Onchocerca volvulus | 0.0263 | 0.471 | 1 | |
Toxoplasma gondii | eukaryotic initiation factor-4A, putative | 0.0205 | 0.3624 | 0.5 |
Giardia lamblia | Translation initiation factor eIF-4A, putative | 0.0205 | 0.3624 | 0.5 |
Leishmania major | protein kinase, putative | 0.0015 | 0.0061 | 0.004 |
Entamoeba histolytica | DEAD/DEAH box helicase, putative | 0.0205 | 0.3624 | 0.5 |
Brugia malayi | hypothetical protein | 0.0185 | 0.3247 | 0.3247 |
Treponema pallidum | ATP-dependent RNA helicase | 0.0205 | 0.3624 | 0.5 |
Trypanosoma cruzi | STE group serine/threonine-protein kinase, putative | 0.0015 | 0.0061 | 0.004 |
Loa Loa (eye worm) | hypothetical protein | 0.0205 | 0.3624 | 0.3624 |
Trypanosoma brucei | Eukaryotic initiation factor 4A-1 | 0.0205 | 0.3624 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.0054 | 0.0054 |
Onchocerca volvulus | 0.0176 | 0.3074 | 0.6526 | |
Trypanosoma cruzi | STE group serine/threonine-protein kinase, putative | 0.0015 | 0.0061 | 0.004 |
Leishmania major | PAS-domain containing phosphoglycerate kinase, putative | 0.0014 | 0.0054 | 0.002 |
Onchocerca volvulus | Eukaryotic initiation factor 4A homolog | 0.0205 | 0.3624 | 0.7694 |
Schistosoma mansoni | aryl hydrocarbon receptor | 0.0055 | 0.0817 | 0.2255 |
Leishmania major | protein kinase, putative | 0.0015 | 0.0061 | 0.004 |
Leishmania major | eukaryotic initiation factor 4a, putative | 0.0205 | 0.3624 | 1 |
Plasmodium vivax | RNA helicase-1, putative | 0.0205 | 0.3624 | 0.5 |
Echinococcus granulosus | eukaryotic initiation factor 4A III | 0.0205 | 0.3624 | 1 |
Brugia malayi | Cytochrome P450 family protein | 0.0014 | 0.0047 | 0.0047 |
Onchocerca volvulus | 0.0014 | 0.0054 | 0.0114 | |
Trypanosoma cruzi | STE/STE11 serine/threonine-protein kinase, putative | 0.0015 | 0.0061 | 0.004 |
Leishmania major | eukaryotic initiation factor 4a, putative | 0.0205 | 0.3624 | 1 |
Schistosoma mansoni | DEAD box ATP-dependent RNA helicase | 0.0205 | 0.3624 | 1 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0205 | 0.3624 | 1 |
Trypanosoma cruzi | STE/STE11 serine/threonine-protein kinase, putative | 0.0015 | 0.0061 | 0.004 |
Brugia malayi | Cytochrome P450 family protein | 0.0014 | 0.0047 | 0.0047 |
Loa Loa (eye worm) | AGC/DMPK/ROCK protein kinase | 0.0546 | 1 | 1 |
Schistosoma mansoni | single-minded | 0.0055 | 0.0817 | 0.2255 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0014 | 0.0047 | 0.0047 |
Echinococcus granulosus | aryl hydrocarbon receptor | 0.0014 | 0.0054 | 0.0148 |
Brugia malayi | PAS domain containing protein | 0.0055 | 0.0817 | 0.0817 |
Brugia malayi | bHLH-PAS transcription factor | 0.0041 | 0.0549 | 0.0549 |
Echinococcus multilocularis | eukaryotic initiation factor 4A III | 0.0205 | 0.3624 | 1 |
Mycobacterium tuberculosis | Probable cold-shock DeaD-box protein A homolog DeaD (ATP-dependent RNA helicase dead homolog) | 0.0205 | 0.3624 | 0.5 |
Trypanosoma cruzi | Eukaryotic initiation factor 4A-1 | 0.0205 | 0.3624 | 1 |
Brugia malayi | eukaryotic initiation factor 4A | 0.0205 | 0.3624 | 0.3624 |
Loa Loa (eye worm) | CYP4Cod1 | 0.0014 | 0.0047 | 0.0047 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0205 | 0.3624 | 1 |
Trypanosoma cruzi | PAS-domain containing phosphoglycerate kinase, putative | 0.0014 | 0.0054 | 0.002 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0014 | 0.0047 | 0.0047 |
Echinococcus multilocularis | transfer RNA-Lys | 0.0041 | 0.0549 | 0.1516 |
Chlamydia trachomatis | two component regulatory system sensor histidine kinase | 0.0014 | 0.0054 | 0.5 |
Echinococcus granulosus | rho-associated protein kinase 1 | 0.0176 | 0.3074 | 0.8482 |
Echinococcus multilocularis | eukaryotic initiation factor 4A | 0.0205 | 0.3624 | 1 |
Echinococcus granulosus | eukaryotic initiation factor 4A | 0.0205 | 0.3624 | 1 |
Schistosoma mansoni | DEAD box ATP-dependent RNA helicase | 0.0205 | 0.3624 | 1 |
Echinococcus multilocularis | rho associated protein kinase | 0.0176 | 0.3074 | 0.8482 |
Loa Loa (eye worm) | aryl Hydrocarbon receptor Associated protein family member | 0.0014 | 0.0054 | 0.0054 |
Loa Loa (eye worm) | hypothetical protein | 0.0185 | 0.3247 | 0.3247 |
Echinococcus granulosus | single minded 2 | 0.0041 | 0.0549 | 0.1516 |
Mycobacterium leprae | Possible regulatory protein | 0.0014 | 0.0054 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.